Determinants of an autism spectrum disorder diagnosis in childhood and adolescence: Evidence from the UK Millennium Cohort Study.


Journal

Autism : the international journal of research and practice
ISSN: 1461-7005
Titre abrégé: Autism
Pays: England
ID NLM: 9713494

Informations de publication

Date de publication:
08 2020
Historique:
pubmed: 6 5 2020
medline: 29 7 2021
entrez: 6 5 2020
Statut: ppublish

Résumé

This study aimed to identify determinants of a late autism spectrum disorder diagnosis, including diagnoses made 'very late' (i.e., in adolescence), using the Millennium Cohort Study, a nationally representative population-based cohort in the United Kingdom. Children diagnosed with autism spectrum disorder by age 14 (N = 581) were included and grouped by the parent-reported timing of diagnosis: before school (up to age 5), during primary school (age 5-11) and during secondary school (age 11-14). Predictors of diagnostic timing, at the child, family and school levels, were investigated using multinomial logistic regression. Most (79%) children with autism spectrum disorder were diagnosed after school entry, and 28% were not diagnosed until secondary school. Among those not diagnosed until secondary school, 75% had been identified at age 5 years by a parent and/or teacher as having socio-behavioural difficulties. Being diagnosed after starting school was predicted by living in poverty (adjusted relative risk ratio: primary = 1.90, 95% confidence interval: 1.03-3.53; secondary = 2.15, 1.05-4.42) and/or having no initial parental concerns (primary = 0.32, 0.15-0.70; secondary = 0.19, 0.09-0.43). Having typical-range intelligence also predicted diagnosis during secondary school. The result indicates that those without cognitive delays and poorer children were at risk of 'very late' (i.e. adolescent) diagnosis. Strategies to promote earlier identification, targeting age at primary school entry, could help those more likely to be diagnosed late.

Identifiants

pubmed: 32367727
doi: 10.1177/1362361320913671
pmc: PMC7645602
doi:

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

1557-1565

Subventions

Organisme : Medical Research Council
ID : MR/N022572/1
Pays : United Kingdom

Références

Psychiatr Serv. 2017 Jan 1;68(1):33-40
pubmed: 27476809
Stat Med. 2011 Feb 20;30(4):377-99
pubmed: 21225900
Dev Med Child Neurol. 2008 Sep;50(9):672-7
pubmed: 18754916
MMWR Surveill Summ. 2018 Apr 27;67(6):1-23
pubmed: 29701730
Pediatrics. 2015 Oct;136(4):e830-7
pubmed: 26371198
J Autism Dev Disord. 2017 Aug;47(8):2519-2534
pubmed: 28527095
J Child Psychol Psychiatry. 2018 Nov;59(11):1143-1151
pubmed: 29672866
J Autism Dev Disord. 2012 Feb;42(2):230-43
pubmed: 21472359
Autism. 2019 Apr;23(3):770-782
pubmed: 29852752
Am J Epidemiol. 2018 Mar 1;187(3):576-584
pubmed: 29165547
J Autism Dev Disord. 2012 Jun;42(6):1183-96
pubmed: 22057879
Paediatr Child Health. 2019 Feb;24(1):e57-e65
pubmed: 30906197
Lancet Psychiatry. 2015 Nov;2(11):1013-27
pubmed: 26544750
J Am Acad Child Adolesc Psychiatry. 2017 Apr;56(4):313-320
pubmed: 28335875
J Dev Behav Pediatr. 2015 Jan;36(1):1-7
pubmed: 25539088
Neurosci Biobehav Rev. 2017 Sep;80:729-742
pubmed: 28642070
J Child Psychol Psychiatry. 2013 Feb;54(2):178-85
pubmed: 22905987
Autism. 2014 Jul;18(5):583-97
pubmed: 23787411
Pediatrics. 2005 Dec;116(6):1480-6
pubmed: 16322174
Autism. 2016 Feb;20(2):153-62
pubmed: 25810370
J Child Psychol Psychiatry. 1997 Jul;38(5):581-6
pubmed: 9255702
J Autism Dev Disord. 2015 Jun;45(6):1766-73
pubmed: 25475364
J Am Acad Child Adolesc Psychiatry. 2009 May;48(5):474-483
pubmed: 19318992
J Dev Behav Pediatr. 2014 Nov-Dec;35(9):561-9
pubmed: 25211371
Arch Dis Child. 2012 Oct;97(10):927-31
pubmed: 22806234
Pediatrics. 2009 Nov;124(5):1395-403
pubmed: 19805460
J Autism Dev Disord. 2016 Jun;46(6):1974-1984
pubmed: 27032954
J Epidemiol Community Health. 2011 Jun;65(6):503-10
pubmed: 20974836
JAMA Pediatr. 2015 Jan;169(1):56-62
pubmed: 25365033
J Autism Dev Disord. 2016 Oct;46(10):3281-94
pubmed: 27457364
Dev Psychopathol. 2008 Summer;20(3):775-803
pubmed: 18606031

Auteurs

Mariko Hosozawa (M)

University College London, UK.
Juntendo University, Japan.

Amanda Sacker (A)

University College London, UK.

William Mandy (W)

University College London, UK.

Emily Midouhas (E)

University College London, UK.

Eirini Flouri (E)

University College London, UK.

Noriko Cable (N)

University College London, UK.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH